SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001453687-21-000124
Filing Date
2021-09-30
Accepted
2021-09-30 08:00:35
Documents
13
Period of Report
2021-09-24
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K selb-20210924.htm   iXBRL 8-K 41494
2 EX-3.2 exhibit32_amendedandrestat.htm EX-3.2 253546
  Complete submission text file 0001453687-21-000124.txt   482470

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT selb-20210924.xsd EX-101.SCH 1946
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT selb-20210924_lab.xml EX-101.LAB 26137
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT selb-20210924_pre.xml EX-101.PRE 13618
6 EXTRACTED XBRL INSTANCE DOCUMENT selb-20210924_htm.xml XML 11700
Mailing Address 65 GROVE STREET WATERTOWN MA 02472
Business Address 65 GROVE STREET WATERTOWN MA 02472 617-923-1400
SELECTA BIOSCIENCES INC (Filer) CIK: 0001453687 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37798 | Film No.: 211293668
SIC: 2834 Pharmaceutical Preparations